Direktorat Registrasi ObatValid

SILDENAFIL CITRATE

Claim this product
BPOM Number
GKL2502509217A1
Approved
1 January 2026
Expiry
31 December 2030
Form
TABLET SALUT SELAPUT

About This Registration

SILDENAFIL CITRATE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL2502509217A1. Its current registration status is Valid, with the licence valid until 31 December 2030. The product is registered to DIPA PHARMALAB INTERSAINS - INDONESIA. BPOM first approved this registration in December 2025. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
newaero
Packaging
DUS, 10 STRIP @ 10 TABLET SALUT SELAPUT
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (1)

SILDENAFIL CITRATE

Market Intelligence

Owner Portfolio
DIPA PHARMALAB INTERSAINS - INDONESIA holds 105 BPOM registrations
Manufacturer Scale
DIPA PHARMALAB INTERSAINS - INDONESIA produces 105 registered products
Registration Age
Registered for 8 months

FDA Cross-Reference

via openFDA
Generic Name
SILDENAFIL CITRATE
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product

More products from DIPA PHARMALAB INTERSAINS - INDONESIA

RIVAROXABAN

-GKL2302508517A1
Valid
Approved: May 24, 2026TABLET SALUT SELAPUT
View product →

RIVACO 20

-DKL2302508417A1
Valid
Approved: May 24, 2026TABLET SALUT SELAPUT
View product →

DOMPERIDONE MALEATE

-GKL2102507910A1
Valid
Approved: Jun 6, 2026TABLET
View product →

EPERISONE HYDROCHLORIDE

-GKL2602509417A1
Valid
Approved: May 5, 2026TABLET SALUT SELAPUT
View product →

NERFLEX

-DKL2602509317A1
Valid
Approved: May 5, 2026TABLET SALUT SELAPUT
View product →

Products in the same class

PIRACETAM

-GKL0933521349A1
Valid
Approved: May 20, 2026INFUS
NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA
View product →

SALBRON

-DKL7804407610B1
Valid
Approved: May 2, 2026TABLET
DANKOS FARMA - INDONESIA
View product →

SANKORBIN

-DKL0822245543A1
Valid
Approved: Apr 24, 2026INJEKSI
SANBE FARMA
View product →

LIDIUM

-DKL2017114117A1
Valid
Approved: Mar 18, 2026TABLET SALUT SELAPUT
HOLI PHARMA - INDONESIA
View product →

AMBROXOL HYDROCHLORIDE

-GKL1015710410A1
Valid
Approved: Mar 16, 2026TABLET
ETERCON PHARMA - INDONESIA
View product →
1